Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Exp Cell Res ; 331(1): 1-10, 2015 Feb 01.
Article in English | MEDLINE | ID: mdl-25499972

ABSTRACT

We have previously demonstrated that the anti-apoptotic protein BAD is expressed in normal human breast tissue and shown that BAD inhibits expression of cyclin D1 to delay cell-cycle progression in breast cancer cells. Herein, expression of proteins in breast tissues was studied by immunohistochemistry and results were analyzed statistically to obtain semi-quantitative data. Biochemical and functional changes in BAD-overexpressing MCF7 breast cancer cells were evaluated using PCR, reporter assays, western blotting, ELISA and extracellular matrix invasion assays. Compared to normal tissues, Grade II breast cancers expressed low total/phosphorylated forms of BAD in both cytoplasmic and nuclear compartments. BAD overexpression decreased the expression of ß-catenin, Sp1, and phosphorylation of STATs. BAD inhibited Ras/MEK/ERK and JNK signaling pathways, without affecting the p38 signaling pathway. Expression of the metastasis-related proteins, MMP10, VEGF, SNAIL, CXCR4, E-cadherin and TlMP2 was regulated by BAD with concomitant inhibition of extracellular matrix invasion. Inhibition of BAD by siRNA increased invasion and Akt/p-Akt levels. Clinical data and the results herein suggest that in addition to the effect on apoptosis, BAD conveys anti-metastatic effects and is a valuable prognostic marker in breast cancer.


Subject(s)
Cell Movement , Down-Regulation , bcl-Associated Death Protein/metabolism , Blotting, Western , Cell Proliferation , Enzyme-Linked Immunosorbent Assay , Epithelial-Mesenchymal Transition , Female , Flow Cytometry , Humans , Immunoenzyme Techniques , MCF-7 Cells , Phosphorylation , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , STAT Transcription Factors/genetics , STAT Transcription Factors/metabolism , Tumor Cells, Cultured , bcl-Associated Death Protein/antagonists & inhibitors , beta Catenin/genetics , beta Catenin/metabolism
2.
Cancer Cell Int ; 13(1): 39, 2013 May 01.
Article in English | MEDLINE | ID: mdl-23631621

ABSTRACT

BACKGROUND: The cancer stem cell (CSC) theory proposes that tumours arise from and are sustained by a subpopulation of cells with both cancer and stem cell properties. One of the key hallmarks of CSCs is the ability to grow anchorage-independently under serum-free culture conditions resulting in the formation of tumourspheres. It has further been reported that these cells are resistant to traditional chemotherapeutic agents. METHODS: In this study, the tumoursphere assay was validated in MCF-7 cells and used to screen novel marine algal compounds for potential anti-cancer stem cell (CSC) activity in vitro. RESULTS: MCF-7 breast cancer cells were observed to generate tumourspheres or mammospheres after 3-5 days growth in anchorage-independent conditions and an apparent enrichment in potential CSCs was observed by an increase in the proportion of CD44high/CD24low marker-bearing cells and Oct4 expression compared to those in the bulk population grown in regular adherent conditions. Using this assay, a set of algal metabolites was screened for the ability to inhibit mammosphere development as a measure of potential anti-CSC activity. We report that the polyhalogenated monoterpene stereoisomers RU017 and RU018 isolated from the red alga Plocamium cornutum, both of which displayed no cytotoxicity against either adherent MCF-7 breast cancer or MCF-12A non-transformed breast epithelial cells, were able to prevent MCF-7 mammosphere formation in vitro. On the other hand, neither the brown algal carotenoid fucoxanthin nor the chemotherapeutic paclitaxel, both of which were toxic to adherent MCF-7 and MCF-12A cells, were able to inhibit mammosphere formation. In fact, pre-treatment with paclitaxel appeared to enhance mammosphere formation and development, a finding which is consistent with the reported resistance of CSCs to traditional chemotherapeutic agents. CONCLUSION: Due to the proposed clinical significance of CSC in terms of tumour initiation and metastasis, the identification of agents able to inhibit this subpopulation has clinical significance.

3.
Bioorg Med Chem Lett ; 21(3): 1015-8, 2011 Feb 01.
Article in English | MEDLINE | ID: mdl-21211967

ABSTRACT

A series of compounds containing 2-substituted imidazoles has been synthesized from imidazole and tested for its biological activity against human African trypanosomiasis (HAT). The 2-substituted 5-nitroimidazoles such as fexinidazole (7a) and 1-[4-(1-methyl-5-nitro-1H-imidazol-2-ylmethoxy)-pyridin-2-yl-piperazine (9e) exhibited potent activity against T. brucei in vitro with low cytotoxicity and good solubility. The presence of the NO(2) group at the 5-position of the imidazole ring in 2-substituted imidazoles is the crucial factor to inhibit T. brucei.


Subject(s)
Imidazoles/chemistry , Trypanocidal Agents/chemistry , Trypanosomiasis, African/drug therapy , Animals , Humans , Imidazoles/chemical synthesis , Imidazoles/therapeutic use , Solubility , Stereoisomerism , Trypanocidal Agents/chemical synthesis , Trypanocidal Agents/therapeutic use , Trypanosoma brucei brucei/drug effects
4.
Anticancer Res ; 30(7): 2497-503, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20682974

ABSTRACT

BACKGROUND: TROP-2 is a tumor-promoting molecule that has been found to be overexpressed in many cancer cells, making it a plausible biomarker of carcinogenesis. The main aim of this study was to examine the effect of green tea catechins (namely, (-)-epigallocatechin-3-gallate; EGCG) on TROP-2 expression. MATERIALS AND METHODS: Western blot and RT-PCR were applied to assess TROP2 expression in colorectal cancer cells and tissues. RESULTS: Two different mechanisms were found to operate in diverse cell lines. In SW480 cells, EGCG affected the post-transcriptional processing of the TROP-2 mRNA, as this was quickly and specifically degraded in the presence of EGCG. In HCT-116 cells, EGCG affected TROP-2 expression at the post-translational level. TROP-2 was found to be highly expressed in colorectal tumors compared to adjacent normal tissues. CONCLUSION: This study provided a novel beneficial activity of green tea as an anti-tumorigenagent causing the suppression of TROP-2 in colorectal cancer.


Subject(s)
Antigens, Neoplasm/metabolism , Catechin/analogs & derivatives , Cell Adhesion Molecules/metabolism , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/metabolism , Protein Processing, Post-Translational/drug effects , Anticarcinogenic Agents/pharmacology , Antigens, Neoplasm/biosynthesis , Antigens, Neoplasm/genetics , Antioxidants/pharmacology , Catechin/pharmacology , Cell Adhesion Molecules/biosynthesis , Cell Adhesion Molecules/genetics , Colorectal Neoplasms/genetics , Dose-Response Relationship, Drug , HCT116 Cells , HT29 Cells , Humans , Protein Biosynthesis/drug effects , RNA, Messenger/biosynthesis , RNA, Messenger/genetics
5.
Exp Ther Med ; 1(1): 181-186, 2010 Jan.
Article in English | MEDLINE | ID: mdl-23136612

ABSTRACT

Coscinium fenestratum (Gaertn.) Colebr. is traditionally used for the treatment of cancer, arthritis and diabetes mellitus. The purpose of this study was to determine the molecular mechanisms by which this plant shows beneficial effects. An 80% ethanolic extract of C. fenestratum (80ET) was separated by its polarity into dichloromethane (DCM) and aqueous fractions (WF), and the anti-proliferative effects of 80ET, DCM and WF were investigated. Berberine, one of the major components of C. fenestratum, was used as a control. The 80ET, DCM, WF and berberine showed anti-proliferative activity as assessed by cell growth assay. Subsequently, the pro-apoptotic proteins NAG-1 and ATF3 were increased and the cell cycle protein cyclin D1 was decreased by the extract and its fractions. Interestingly, only the DCM fraction exhibited the induction of peroxisome proliferator-activated receptor γ (PPARγ) binding activity, which represents a pro-apoptotic activity in colorectal cancer cells. The overall results of this study indicate that the extract from this plant has anti-proliferative activity through the activation of pro-apoptotic proteins and PPARγ, and may have potential as a preventive regimen in the treatment of cancer.

6.
Biochem Biophys Res Commun ; 391(3): 1385-9, 2010 Jan 15.
Article in English | MEDLINE | ID: mdl-20026301

ABSTRACT

Expression of cyclooxygenases (COX) and lipoxygenases (LOX) has been linked to many pathophysiological phenotypes, including cell adhesion. However, many current approaches to measure cellular changes are performed only in a fixed-time point. Since cells dynamically move in conjunction with the cell matrix, there is a pressing need for dynamic or time-dependent methods for the investigation of cell properties. In the presented study, we used stable human colorectal cancer cell lines ectopically expressing COX-1, COX-2, and 15LOX-1, to investigate whether expression of COX-1, COX-2, or 15LOX-1 would affect cell adhesion using our opto-electric methodology. In a fixed-time point experiment, only COX-1- and COX-2-expressing cells enhanced phosphorylation of focal adhesion kinase, but all the transfected cells showed invasion activity. However, in a real-time experiment using opto-electric approaches, transmitted cellular morphology was much different with tight adhesion being shown in COX-2 expressing cells, as imaged by differential interference contrast microscopy (DICM) and interference reflection contrast microscopy (IRCM). Furthermore, micro-impedance measurements showed a continued increase in both resistance and reactance of COX- and LOX-transfected cells, consistent with the imaging data. Our data indicate that both COX- and LOX-expressing cells have strong cell-to-cell and cell-to-substrate adhesions, and that cell imaging analysis with cell impedance data generates fully reliable results on cell adhesion measurement.


Subject(s)
Arachidonate 15-Lipoxygenase/metabolism , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/metabolism , Neoplasms/pathology , Arachidonate 15-Lipoxygenase/genetics , Cell Adhesion , Cell Line, Tumor , Cyclooxygenase 1/genetics , Cyclooxygenase 2/genetics , Electric Impedance , Humans , Microscopy/methods , Neoplasm Invasiveness , Neoplasms/enzymology , Transfection
7.
J Nutr Biochem ; 21(2): 98-106, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19157820

ABSTRACT

The main aims of this study were to elucidate the effect of green tea catechins on Nudix-type motif 6 (NUDT6) suppression and to characterize NUDT6's biological activity. Our microarray data showed that the green tea component epicatechin-3-gallate suppressed NUDT6 expression, and this was confirmed by RT-PCR. Subsequently, the use of different catechins showed that the effect of epigallocatechin-3-gallate (EGCG) was stronger than that of other catechins. At the posttranscriptional level, EGCG decreased the RNA stability of NUDT6, indicating it as a potential mechanism of NUDT6 suppression. Further cloning of the 3' untranslated region of human NUDT6 mRNA resulted in reduced luciferase activity by EGCG treatment. This effect was at least, in part, mediated by the extracellular-signal-regulated kinase and p38MAPK pathways. Finally, increased cell proliferation and cell growth in soft agar were observed in NUDT6-overexpressing cells. These findings provide a novel mechanism for the suppression of the proliferative gene NUDT6 by green tea catechins in human colorectal cancer.


Subject(s)
Anticarcinogenic Agents/pharmacology , Catechin/analogs & derivatives , Cell Proliferation/drug effects , Down-Regulation/drug effects , Proteins/physiology , RNA Stability/drug effects , RNA, Messenger/metabolism , Tea/chemistry , 3' Untranslated Regions/drug effects , Catechin/pharmacology , Cell Adhesion/drug effects , Cell Line, Tumor , Colorectal Neoplasms/prevention & control , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Half-Life , Humans , Oligonucleotide Array Sequence Analysis , Proteins/genetics , Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors
8.
Med Chem ; 5(3): 293-300, 2009 May.
Article in English | MEDLINE | ID: mdl-19442220

ABSTRACT

Febrifugine and its derivatives including halofuginone which possess very high activity against malaria were prepared synthetically from easily available starting material, 3-hydroxy picoline, and using simple reaction conditions. Synthesis of 2-amino-5, 6-methylenedioxy benzoic acid, (which is an intermediate for the process) is described. The selectivity enhancement in nitration of 3, 4-methylenedioxybenzaldehyde towards 6-nitro isomer was done with the help of surfactant. The antimalarial activity of synthesized compounds was determined by using in vitro assays against chloroquine sensitive (D6), chloroquine resistant (W2) Plasmodium falciparum strains for susceptibility and two mammalian cell lines (neuronal cell line NG108 and macrophage cell line J774) for cytotoxicity. The IC(50)s of halofuginone was observed to be the best among the synthesized derivatives of febrifugine.


Subject(s)
Antimalarials/chemical synthesis , Antimalarials/pharmacology , Piperidines/chemical synthesis , Piperidines/pharmacology , Quinazolines/chemical synthesis , Quinazolines/pharmacology , Quinazolinones/chemical synthesis , Quinazolinones/pharmacology , Animals , Antimalarials/chemistry , Benzoates/chemical synthesis , Cell Line , Piperidines/chemistry , Plasmodium falciparum/drug effects , Quinazolines/chemistry
9.
Cancer Prev Res (Phila) ; 2(5): 450-8, 2009 May.
Article in English | MEDLINE | ID: mdl-19401523

ABSTRACT

The expression of nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) inhibits gastrointestinal tumorigenesis in NAG-1 transgenic mice (C57/BL6 background). In the present study, we investigated whether the NAG-1 protein would alter urethane-induced pulmonary lesions in NAG-1 transgenic mice on an FVB background (NAG-1(Tg+/FVB)). NAG-1(Tg+/FVB) mice had both decreased number and size of urethane-induced tumors, compared with control littermates (NAG-1(Tg+/FVB) = 16 +/- 4 per mouse versus control = 20 +/- 7 per mouse, P < 0.05). Urethane-induced pulmonary adenomas and adenocarcinomas were observed in control mice; however, only pulmonary adenomas were observed in NAG-1(Tg+/FVB) mice. Urethane-induced tumors from control littermates and NAG-1(Tg+/FVB) mice highly expressed proteins in the arachidonic acid pathway (cyclooxygenases 1/2, prostaglandin E synthase, and prostaglandin E(2) receptor) and highly activated several kinases (phospho-Raf-1 and phosphorylated extracellular signal-regulated kinase 1/2). However, only urethane-induced p38 mitogen-activated protein kinase (MAPK) phosphorylation was decreased in NAG-1(Tg+/FVB) mice. Furthermore, significantly increased apoptosis in tumors of NAG-1(Tg+/FVB) mice compared with control mice was observed as assessed by caspase-3/7 activity. In addition, fewer inflammatory cells were observed in the lung tissue isolated from urethane-treated NAG-1(Tg+/FVB) mice compared with control mice. These results paralleled in vitro assays using human A549 pulmonary carcinoma cells. Less phosphorylated p38 MAPK was observed in cells overexpressing NAG-1 compared with control cells. Overall, our study revealed for the first time that the NAG-1 protein inhibits urethane-induced tumor formation, probably mediated by the p38 MAPK pathway, and is a possible new target for lung cancer chemoprevention.


Subject(s)
Carcinogens/toxicity , Growth Differentiation Factor 15/genetics , Lung Neoplasms/genetics , Signal Transduction/physiology , Urethane/toxicity , Animals , Apoptosis/physiology , Blotting, Western , Cell Line, Tumor , Growth Differentiation Factor 15/metabolism , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Lung Neoplasms/chemically induced , Lung Neoplasms/metabolism , Mice , Mice, Transgenic , Reverse Transcriptase Polymerase Chain Reaction , p38 Mitogen-Activated Protein Kinases/metabolism
10.
Gastroenterology ; 134(7): 1972-80, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18549879

ABSTRACT

BACKGROUND & AIMS: Green tea catechins are known to have anticarcinogenic effects. Epigallocatechin-3-gallate (EGCG) accounts for almost 50% of the total catechin content in green tea extract and has very potent antioxidant effects. EGCG also inhibits angiogenesis, possibly through the inhibition of proangiogenic factors including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), which in turn, inhibits tumor growth and metastasis. However, the exact molecular mechanism by which EGCG suppresses bFGF expression is not known. Our objective was to elucidate the molecular mechanisms by which EGCG inhibits bFGF expression in colorectal cancer. METHODS: We examined posttranslational regulation of bFGF by EGCG in human colorectal cancer cells. We also examined bFGF in intestinal tumor formation of APC(Min/+) mice with and without catechin treatment. RESULTS: The bFGF protein was quickly degraded in the presence of EGCG, but a proteasome inhibitor suppressed this degradation. EGCG was also found to increase ubiquitination of bFGF and trypsin-like activity of the 20S proteasome, thereby resulting in the degradation of bFGF protein. Furthermore, EGCG suppressed tumor formation in APC(Min/+) mice, compared with vehicle-treated mice, in association with reduced bFGF expression. CONCLUSIONS: The ubiquitin-proteasome degradation pathway contributes significantly to down-regulation of bFGF expression by EGCG. Catechin compounds have fewer adverse effects than chemotherapeutic agents and hence can be used as proof-of-concept in cancer therapeutics to suppress growth and metastasis by targeting proteins such as bFGF.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Camellia sinensis , Catechin/analogs & derivatives , Colorectal Neoplasms/drug therapy , Fibroblast Growth Factor 2/metabolism , Protein Processing, Post-Translational/drug effects , Acetylcysteine/analogs & derivatives , Acetylcysteine/pharmacology , Adenomatous Polyposis Coli/genetics , Adenomatous Polyposis Coli/metabolism , Adenomatous Polyposis Coli/prevention & control , Animals , Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/therapeutic use , Camellia sinensis/chemistry , Catechin/isolation & purification , Catechin/pharmacology , Catechin/therapeutic use , Cell Transformation, Neoplastic/drug effects , Cell Transformation, Neoplastic/metabolism , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/prevention & control , Cycloheximide/pharmacology , Cysteine Proteinase Inhibitors/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Down-Regulation , Fibroblast Growth Factor 2/genetics , Genes, APC , HCT116 Cells , HT29 Cells , Humans , Mice , Proteasome Endopeptidase Complex/metabolism , Proteasome Inhibitors , Protein Synthesis Inhibitors/pharmacology , Time Factors , Transfection
11.
Cancer Lett ; 258(2): 230-40, 2007 Dec 18.
Article in English | MEDLINE | ID: mdl-17964072

ABSTRACT

Berberine is known to possess a wide variety of pharmacological activities, including pro-apoptotic activity. However, its molecular targets are not elucidated at present. NAG-1 and ATF3 are induced by several dietary compounds associated with pro-apoptotic activity. Berberine induces cell growth arrest, apoptosis, NAG-1, and ATF3 in human colorectal cancer cells. ATF3 induction by berberine is mediated in a p53-dependent manner, whereas NAG-1 induction by berberine is mediated by multiple signaling pathways. Our results suggest that berberine facilitates apoptosis and that NAG-1 and ATF3 expression plays an important role in berberine-induced apoptosis.


Subject(s)
Activating Transcription Factor 3/metabolism , Apoptosis/drug effects , Berberine/pharmacology , Cell Proliferation/drug effects , Cytokines/metabolism , Activating Transcription Factor 3/genetics , Alkaloids/pharmacology , Biological Products/pharmacology , Blotting, Western , Cell Line, Tumor , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Cytokines/genetics , Dose-Response Relationship, Drug , Flow Cytometry , Growth Differentiation Factor 15 , HCT116 Cells , Humans , Isoquinolines/pharmacology , Luciferases/genetics , Luciferases/metabolism , Protein Kinase Inhibitors/pharmacology , RNA, Small Interfering/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Transcription, Genetic/genetics , Transfection , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism
12.
Eur J Cancer ; 43(16): 2404-12, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17764926

ABSTRACT

Epicatechin gallate (ECG) is the third major catechin component in green tea, but it shows strong biological activity in some aspects, including apoptosis, cell growth inhibition, and membrane transport system in various cells. We previously reported that ECG induces activating transcription factor 3 (ATF3), which is involved in pro-apoptosis in HCT-116 cells. In this report, we present a molecular mechanism by which ECG induces ATF3 expression at the transcriptional level. We found that Sp3 contributed to the basal expression of the ATF3 gene, whereas EGR-1 played an important role in ECG-induced ATF3 expression in HCT-116 cells, as assessed by EMSA and co-transfection experiments. These results suggested that EGR-1, a tumour suppressor protein, could substantiate ECG's role of ATF3 expression in human colorectal cancer cells. We also found that pro-oxidant activity of ECG contributed to ECG-induced ATF3 expression.


Subject(s)
Activating Transcription Factor 3/metabolism , Antioxidants/pharmacology , Camellia sinensis , Catechin/analogs & derivatives , Early Growth Response Protein 1/metabolism , Tea , Apoptosis/drug effects , Catechin/pharmacology , Female , Humans , Male , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...